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INTRODUCTION
Post‑operative sore throat (POST) is a common 
undesirable consequence of tracheal intubation. The 
prevalence of POST ranges from 21% to 65% after 
tracheal intubation varying in accordance with the 
mechanical trauma during intubation, tracheal tube 
cuff pressure leading to mucosal erosion, mucosal 
inflammation and dehydration.[1,2] In addition to a 
negative impact on patient satisfaction and recovery, 
POST increases the expenditure of health care.[3]
A number of non‑pharmacological methods as well 
as pharmacological agents have been used to mitigate 
the condition. Non‑pharmacological methods include 
use of supraglottic airway device instead of tracheal 
tube, smaller tubes, limiting cuff pressure and gentle 
oropharyngeal suctioning.[4,5] Various pharmacological 
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ABSTRACT
Background and Aims: Post‑operative sore throat (POST) is a common undesirable consequence 
of tracheal intubation. Magnesium, an N‑methyl‑D‑aspartate receptor antagonist, has anti‑nociceptive 
and anti‑inflammatory properties, and has been found to be useful in POST prevention in various 
trials. We conducted this systematic review and meta‑analysis to study the efficacy of topical 
magnesium in preventing POST in adult patients undergoing surgery under general anaesthesia 
with single lumen tracheal tube. Methods: Comprehensive literature search was performed in 
PubMed, Google Scholar, EMBASE, Scopus and the Cochrane central registers of controlled 
trial databases through July, 2018 and data were pooled using fixed effect modelling followed 
by random‑effect methods (after assessing heterogeneity with fixed modelling). The primary 
outcome was the incidence of POST at 24 h after surgery/extubation. Comparative results were 
deliberated as pooled mean difference for continuous variables and Mantel–Haenszel (MH) 
odds ratio for dichotomous variables. Statistical analysis was done using Comprehensive 
Meta‑Analysis‑Version 3 (Biostat Inc., USA). Results: Seven trials involving 726 study participants 
were included in the final analysis. Incidence of POST at 24 hours was significantly lower in 
magnesium group (26/363) in comparison to active and non‑active control group (89/363); 
P = 0.00‑ RR 0.22 (95%CI = 0.12‑0.39, I2 = 0%). No significant adverse events were reported with the 
use of topical magnesium. Conclusion: Prophylactic use of topical magnesium before the induction 
of general anaesthesia seems to be an effective measure to decrease the incidence of POST.
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agents like lignocaine, steroids and ketamine have 
been used with varying degree of success to reduce 
the incidence as well as severity of POST.[6-10]
Magnesium, an N-methyl-D-aspartate receptor 
antagonist found in central as well as peripheral nervous 
system, has anti-nociceptive and anti-inflammatory 
properties; therefore, it has been hypothesised to be 
useful for POST prevention.[11] Prophylactic efficacy of 
magnesium has been assessed by various randomised 
controlled trials showing controversial results.[12-19] 
To our knowledge, however, no systematic review 
has summarised the magnitude of their prophylactic 
efficacy from the numerous randomised trials 
published. Our group conducted this systematic 
review and meta-analysis of prospective randomised 
trials to study the efficacy of topical magnesium in 
preventing POST in adult patients undergoing surgery 
under general anaesthesia with single lumen tracheal 
tube.
METHODS
Cochrane collaboration methodology[20] and Preferred 
Reporting Items for Systematic Reviews and 
Meta-Analyses PRISMA[21] statement were followed 
for the conduct of our systematic meta-analysis. 
Following are the eligibility criteria.
Study type: Only randomised controlled trials were 
considered for enrolment.
Population: Publication on effect of administration 
of topical magnesium sulphate in the preoperative 
period on incidence of POST at 24 h in adult patients 
proceeding with surgery under general anaesthesia 
was included.
Intervention and comparators: Patients receiving 
magnesium sulphate as nebulisation/gargles were 
considered the intervention group. Non-active controls 
included normal saline or placebo, whereas active 
controls included the use of agents, such as aspirin 
and ketamine with a known impact on POST.
Outcome: The primary outcome was the incidence 
of POST in 24 h after surgery/extubation. Studies 
through inception to July 2018 were included in this 
meta-analysis. Our search included trials published 
in both English and non-English languages. Studies, 
which were published as letter to editor with 
incomplete data, were excluded.[12]
Data extraction
Comprehensive literature search was performed in 
PubMed, Google Scholar, EMBASE, Scopus and the 
Cochrane central registers of controlled trial databases 
through July 2018. Search terms ‘postoperative sore 
throat’, ‘tracheal tube’, ‘magnesium’, ‘randomised 
clinical trial’, ‘adult’ and ‘severity’ in various 
combinations were used. Parallel-group, randomised 
controlled design showing comparison of topical usage 
of magnesium sulphate with either non-analgesic or 
active control; recruiting adult patients undergoing 
surgery under general anaesthesia with single lumen 
tracheal tube disclosing the incidence and severity of 
POST 24 h after surgery/extubation were included in 
the meta-analysis. Search was extended to research 
articles published either as full manuscripts or abstracts 
of meeting in peer-reviewed journals. References 
of comparable meta-analysis were also searched 
manually for relevant trials. Our search included trials 
published in both English and non-English languages. 
Once the abstract was analysed by the searching 
reviewer and found appropriate, full text of the article 
was further studied.
Two authors (NPS and JKM) independently reviewed 
all articles and relevant articles were selected. 
Disagreements were resolved through discussion and 
in case of any disagreement, PMS was consulted. NPS 
and JKM independently extracted data pertaining 
to demographic profile of the patients; year and 
country of trial, surgery performed; size of tracheal 
tube, tracheal cuff pressure, duration of intubation, 
interventions used, incidence of POST at various time 
intervals, severity of POST, cough and post-operative 
hoarseness. Duplicates obtained from individual 
search by different reviewers were identified and were 
removed using Endnote (Thompson Reuters, USA). 
Data were abstracted into a standardised format entered 
into Microsoft Excel 2016 (Microsoft Corporation, 
USA). Cross-references of relevant articles were then 
searched to ensure enrolment of all eligible studies.
Assessment of bias and quality of evidence
Risk of bias was assessed using the Cochrane risk of bias 
assessment tool.[20] Each randomised trial was assessed 
based upon seven domains of potential bias (random 
sequence generation, allocation concealment, blinding 
of intervention, blinding of outcome assessment, 
incomplete outcome data, selective reporting and other 
bias). The overall risk of bias of individual studies was 
classified as high-risk if at least two domains were 
determined at high-risk or if there were more than 
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two domains of unclear risk, moderate risk if at least 
two domains were determined at unclear risk, and 
low risk if all the domains were determined at low 
risk. The grading of recommendations, assessment, 
development and evaluation (GRADE) system was 
used to assess quality of evidence as high, moderate, 
low or very low.[22]
Outcome measures and statistical analysis
The primary outcome was the incidence of POST 
in 24 h after surgery/extubation. Incidence of POST 
at 6 h, and severity of POST were the secondary 
outcomes analysed. The Mantel–Haenszel (MH) odds 
ratio (OR) was calculated for dichotomous outcomes 
and standardised mean differences for continuous 
outcomes. Data were presented with the corresponding 
95% confidence interval (CI). In case data were 
presented as median with interquartile range, method 
proposed by Wan et al.[23] was used to convert the 
values to mean and standard deviation. Statistical 
heterogeneity was tested using the I2[24] and Q statistics 
Egger’s method[25] was used to assess small study effect 
or publication bias. Values of I2 < 40%, 40%–60%, 
60%–90% were considered non-significant, moderate 
heterogeneity and high heterogeneity, respectively.[24]
Primary analyses were performed pooling both 
non-active and active (analgesic) controls. In case a trial 
had more than one arm of intervention, control arm was 
considered separately with comparator (magnesium) 
for primary analysis.
Comprehensive Meta-Analysis-Version 3 (Biostat Inc., 
USA) was used for the statistical analysis. Fixed effect 
modelling followed by with random-effect methods 
(after assessing heterogeneity with fixed modelling) was 
used for performing the meta-analysis. Comparative 
results were deliberated as pooled mean difference 
for continuous variables and Mantel–Haenszel (MH) 
OR for dichotomous variables. P < 0.05 was deemed 
statistically significant. ‘Fixed effect modelling’ were 
used when heterogeneity was found to be lower than 
40% otherwise results from random effect modelling 
are presented. Egger’s regression test was used to 
quantify publication bias and was further judged by 
the usage of funnel plot.
RESULTS
Literature search
Initial search yielded 199 titles and abstracts. A total 
of 7 trials involving 726 study participants were 
included in the final analysis. The process of screening 
and inclusion of RCTs is shown in Figure 1. One trial 
by Gupta et al.[12] evaluated the efficacy of nebulised 
magnesium sulphate for attenuating POST. Though 
authors reported decrease in incidence and severity of 
POST till 24 h, actual data were not reported in this 
letter to editor.
Study characteristics [Table 1]
All the authors monitored the cuff pressure and kept it 
below 25–30 cm of H2O throughout the study duration. 
Reported tube size was also fairly constant across all 
the trials. All the female participant’s tracheas were 
intubated with tubes of outer diameter 7–7.5 mm and 
8–8.5 mm size was used for male patients. Duration 
of tracheal intubation was reported by most of the 
authors and it ranged from 51 to 120 min.
Only one trial[16] included participants undergoing 
emergency surgery (i.e., acute appendicitis) and the 
rest of the trials enrolled elective surgeries, such as 
spine, abdominal and orthopaedic procedures.[13-16,17-19] 
Magnesium was given through topical routes, namely, 
nebulisation in four trials,[13,15,18,19] gargles in two 
studies[14,16] and lozenges[17] was used in one trial. 
Nebulisation dose of magnesium ranged from 225 to 
250 mg; 20 mg/kg was given through gargling across the 
trials and 100-mg lozenges were used. Non-analgesic 
controls were normal saline in four trials and placebo 
in one trial. The comparator agent with known 
analgesic was ketamine in three trials[13,16,19] and 
aspirin in one trial.[14] Information on characteristics 
of patient, anaesthetic techniques, surgical procedures 
and number of interventions are listed in Table 1. 
Trial by Rajan et al. and Jain et al. compared three 
groups (two active and one control) as the values of 
individual groups were reported separately; we were 
able to obtain two comparisons for pooled results 
from both these studies. These comparison arms are 
labelled as (1) and (2) for better reader comprehension 
and to avoid group identification confusion.
In one trial, the study participants were in prone 
position for surgery;[18] in three trials, surgery was 
undertaken with patients in supine position[13,16,19] and 
the remaining three studies did not mention the surgical 
position.[14,15,17] Only one trial used succinylcholine as 
muscle relaxant for intubation,[16] whereas the rest of the 
researchers used non-depolarizing muscle relaxants.
The study participant’s mean age was 37.14 ± 10.66 
in control group and 36.86 ± 10.22 in comparator 
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group. One group of researchers enrolled only female 
participants,[19] one group did not report patient’s 
gender,[13] but others enrolled subjects of either sex.[14-18] 
Control and treatment groups in the reported trials had 
comparable distribution of genders. Six trials included 
patients with ASA physical status 1–2,[14-19] whereas 
only one trial included patients with ASA physical 
status 1–3.[19]
Study quality assessment
Figure 2 shows the methodological qualities of 
selected studies. Methods of allocation generation 
were described in four trials,[13,14,17,19] and two 
studies provided the detailed methods of allocation 
concealment.[17-19] Four studies provided detailed 
information regarding the blinding of patients as well 
as assessors.[13,14,17,19]
Primary outcome
Data of sore throat 24 h postoperatively were 
available in 7 trials that included 363 patients in 
control and 363 patients in the comparator group. 
Incidence of POST was significantly lower in 
comparator group (26/363) in comparison to control 
group (89/363); P = 0.00, RR 0.22 (95% CI = 0.12–0.39 
I2 = 0%) [Figure 3]. All these seven trials reporting the 
primary outcome were also further sub-grouped based 
upon the use of non-active control. On subgroup 
analysis, incidence of POST was significantly lower 
in the comparator group (12/220) as compared to the 
non-active control group (57/220); P = 0.00. RR 95% 
CI 0.18 (0.09–0.36). Four trials used known analgesic 
agents as comparator. The active comparator was 
ketamine in three trials and aspirin in one trial. When 
compared with ketamine or aspirin, there was no 
statistically significant difference in the incidence of 
sore throat with use of magnesium.
Topical magnesium reduced the severity of POST 
by nearly 78% as compared to the control group at 
24 h after surgery. The number needed to treat for 
reduction of one episode of sore throat with the use 
Figure 1: Flowchart showing selection of RCT for meta-analysis
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of magnesium was 5.76. This comparison had ‘zero’ 
overall heterogeneity.
Secondary outcomes
Incidence of early sore throat
Sore throat at 6 h: The incidence of sore throat 
at 6 h was available in all the seven trials. 
Incidence of sore throat was significantly lower 
in the comparator group 66/363 in comparison 
to the control group 141/363; P < 0.001, RR 
0.22 (95%CI = 0.14–0.34 I2 = 68.31%, random 
effects) [Figure 4]. This amounted to a reduction of 
78% in the incidence of sore throat in comparison 
to the control group. Number needed to treat (NNT) 
for prevention of single episode of early sore throat 
with the use of magnesium was 4.84. Grade quality 
of evidence was judged to be high.
We performed a sensitivity analysis using ‘single 
study removal method’ to explore for the high 
heterogeneity for this variable. The study by Rajan 
et al. contributed highly to the heterogeneity and on 
excluding ketamine arm of the trial, the heterogeneity 
dropped to 49.14%.
Severity of sore throat
Six trials provided information on severity of sore 
throat. None of the patients developed severe sore 
throat in any of the studies.
Mild severity: The incidence of mild sore throat was 
disclosed in six trials. The overall incidence of mild 
sore throat was 12/248 in the magnesium group 
compared to 28/248 in the control group. The MH 
OR for mild sore throat with the usage of magnesium 
was 0.43 (95%CI being 0.21–0.87) [P = 0.02, 
I2 = 0%] [Figure 5]. This amounted to nearly 57% 
reduction in incidence of mild sore throat with the use 
of magnesium with an NNT of 15.50. Grade quality of 
evidence was judged to be moderate.
Moderate sore throat: This variable was reported by 
5 trials that included 213 patients each in magnesium 
and control groups. Incidence of moderate sore throat 
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Magnesium led to reduction of moderate degree of 
sore throat by around 85% over control group with an 
NNT of 11.21.
Comparison with ketamine: Magnesium usage was found 
to be comparable to topical ketamine, reported in 3 trials 
with 230 patients in preventing sore throat at 24 h, MH 
OR was 0.53 (95%CI being 0.14–1.97) [P = 0.34].
Only four studies commented on incidence of 
hoarseness and cough at 24 h. No cough or hoarseness 
was found at 24 h in three studies and in one trial 
only one patient had hoarseness at 24 h.[14] Three trials 
reported the information on adverse events associated 
with study drug.
Publication bias
Both funnel plot and Egger’s regression test were 
used to evaluate for the publication bias in 24-h 
incidence of sore throat (primary variable). There was 
a symmetrical distribution of trials on Funnel plot. 
Egger’s test demonstrated an X-axis intercept at 0.096 
with P values of 0.916 (two-tailed) [Figure 7]. Both 
these indicated that the publication bias was unlikely.
DISCUSSION
We conducted this meta-analysis to assess the efficacy 
of topical magnesium in preventing POST in adult 
Figure 3: Forest plot showing comparison of magnesium with control in 24 h
was 0.04% and 9.38% with magnesium and control, 
respectively. The MH OR for sore throat with usage of 
magnesium as compared to control was 0.15 (95%CI 
being 0.05–0.5), [P = 0.00, I2 = 0%] [Figure 6]. 
Figure 2: Risk of bias summary
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patients undergoing surgery with general anaesthesia 
and oral intubation. We found that magnesium is 
an effective agent to reduce the incidence of POST. 
Prophylactic use of magnesium against POST is 
also associated with a reduction in severity of this 
undesirable post-operative complication.
POST is a minor but distressing post-operative 
complication. Only a limited number of research 
articles on airway complications have studied 
POST, even though it hampers the patient’s recovery 
and potential increased health care cost.[26-28] In 
this systematic review, use of magnesium was 
Figure 5: Forest plot depicting incidence of mild sore throat for magnesium and control at 24 h
Figure 4: Forest plot showing comparison of magnesium with control at 6 h
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Figure 6: Forest plot showing incidence of moderate sore throat for magnesium and control at 24 h
Figure 7: Funnel plot of standard error
associated with significant reduction in incidence 
of sore throat during the first 24 h after surgery 
in comparison with placebo group without any 
significant adverse effect documented. The number 
needed to prevent POST when using magnesium 
was 5.76 indicating a large prophylactic effect. 
Grade quality of evidence for incidence of POST 
reduction with use of magnesium was high. Use of 
this drug reduced the severity of POST by nearly 
78%. Among the deleterious outcomes secondary 
to POST in patients, the most important are 
delayed discharge, discomfort and even dangerous 
sympathetic response. However, we were not 
able to measure the effect of magnesium on these 
POST-related outcomes because of the lack of 
information in the trials included.
The trigger of POST is usually pharyngolaryngeal 
mucosal inflammation secondary to localised trauma 
inflicted by cuff of tracheal tube. Therefore, a high 
number of anti-inflammatory agents have been 
proposed to be effective in reducing POST.[29-32] Tanaka 
et al., in their meta-analysis reported positive results 
with lignocaine that were dependent on study quality; 
drug concentration; route of administration and 
management of cuff pressure during anaesthesia.[33] 
Administration of ketamine gargle prior to induction of 
general anaesthesia with airway instrumentation was 
found to improve patient satisfaction by decreasing 
patient discomfort and the need for adjunct pain 
therapy in a meta-analysis conducted by Mayhood 
et al.[34] Corticosteroids applied to tracheal tubes were 
superior both to non-analgesic controls and lignocaine, 
in preventing POST in a meta-analysis conducted by 
Kuriyama et al.[35] Same group of authors conducted 
another meta-analysis to assess the efficacy and safety 
of topical application of benzydamine to prevent POST 
in adults undergoing elective surgery under general 
anaesthesia.[36] Authors found that benzydamine was 
also associated with a reduced incidence of POST 
when compared with lignocaine. However, the effects 
of benzydamine hydrochloride on the incidence of 
POST have only been compared in small trials.
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Consolidated standards of reporting trials (CONSORT) 
statement requires trial investigators to report on 
harms associated with interventions.[37] Though all 
seven trials were published after publication of this 
statement; four trials did not report adverse effects 
of their intervention.[14,16,18,19] Our analysis of the 
limited evidence available suggests that topical use of 
magnesium is not associated with greater incidence of 
adverse events. As for the potential side effects of topical 
magnesium like gastric irritation, diarrhoea or nausea 
were noted in one trial[17] and author did not observe 
any of these side effects. Other three studies[14,15,18] did 
not define the side effects they had noticed. However, 
they reported absence of any adverse effects.
Magnesium was administered as gargles, lozenges or 
nebulisation 15–30 min before surgery in preoperative 
area. Only one study defined the size of droplets 
produced by the nebuliser. Jain et al. used nebuliser 
that produced droplets of size 5–8 microns resulting 
in only 37%–60% of the drug getting deposited in 
oropharynx. Nebulisation ensures that the drug 
is equally and effectively distributed all over the 
pharynx and up to the beginning of the respiratory 
tract. In addition, nebulisation prevents the user 
variability associated with gargling and confounded 
the issue of taste of the medications.[19] Lozenges 
used allow immediate release of the drug, which 
adheres to the pharyngeal wall and decreases the 
oedema. Further magnesium thus released has local 
analgesic and anti-inflammatory effects, especially 
in the presence of alkaline pH, in which magnesium 
is highly concentrated in inflamed tissue and has 
minimal systemic absorption. This prolongs the action 
and decreases possibility of side effects.[17]
One of the strengths of our meta-analysis was that 
greater proportion of enrolled randomised controlled 
trials used a similar route of administration and dose 
of magnesium. Furthermore, our analysis showed 
no heterogeneity. In addition to incidence of POST, 
we were also able to define the effect of magnesium 
on severity of POST as five out of seven trials had 
data pertaining to severity also. Third, we used 
the Cochrane methodology when performing this 
systematic review. Quality of evidence was assessed 
using the GRADE criteria. We further confirmed the 
robustness of our findings using sub-group sensitivity 
and trial sequential analyses.
There are few limitations of this meta-analysis. First, 
the minimum dose of magnesium required for optimal 
effect could not be defined as most of the studies used 
similar doses. Second, only the effect of magnesium as 
compared to placebo could be studied because of the 
limited number of studies comparing magnesium with 
active control. Though our results suggest that topical 
magnesium is associated with reduced sore throat, 
our study was not able to prove whether it is better 
than or equivalent to other agents like lignocaine, 
corticosteroids or ketamine. We could not perform a 
meta-regression analysis because of limited number of 
studies. We could not adjust for variables like higher 
cuff pressure and larger tracheal tubes size, which are 
known risk factors for POST. Additionally, as only four 
trials collected the data on adverse events associated 
with magnesium, we could not assess the safety of the 
drug. Publication bias is present in some outcomes 
despite our comprehensive search
CONCLUSION
Prophylactic topical magnesium, before the induction 
of general anaesthesia, seems to be an effective measure 
to decrease the incidence of POST. We encourage 
the use of this agent in clinical practice and suggest 
further studies that assess the impact of magnesium 
on patient’s recovery and the cost-effectiveness of this 
strategy.
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